Identification and characterization of molecules important in the immune system
免疫系统中重要分子的鉴定和表征
基本信息
- 批准号:7126607
- 负责人:
- 金额:$ 16.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-06 至 2008-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Understanding the genetic mechanisms that promote lineage commitment and eliminate autoreactive thymocytes in the thymus has direct relation to human disease. My research involves identifying new molecules important in the development and differentiation of the thymus, and characterizing their molecular basis in regulating immune responses to both self and non-self. Studying and understanding self-tolerance mechanisms may result in therapeutic treatments for patients with harmful autoimmune diseases.
My experimental design involves the identification and characterization of novel molecules necessary for proper cell development and differentiation. I use genomics (Serial Analysis of Gene Expression) to
identify specific gene products differentially expressed in distinct T cell populations. I then characterize the molecules with a novel RNAi method to generate gene-specific deficient mice. In brief, lentivirus containing gene specific shRNA is introduced into purified hematopoetic stem cells (HSC's). RAG2 -/- recipient mice are then reconstituted with HSC's to generate gene-specific knockdown mice.
With these combined genomic and RNAi-based methodologies I identified and characterized MINK
(Misshapen-NIK-related kinase), which is important for negative selection in the thymus. Further, I aim to extend the use of these approaches to characterize other molecules identified by SAGE.
This research will contribute to identifying new molecules important for immune responses and
self-tolerance. Moreover, the rapid characterization of their biological functions will help to understand and find the proper targets for treating autoimmune diseases.
描述(由申请人提供):了解促进谱系定型和消除胸腺中自身反应性胸腺细胞的遗传机制与人类疾病有直接关系。我的研究涉及识别在胸腺的发育和分化中重要的新分子,并表征其在调节自身和非自身免疫反应中的分子基础。研究和理解自身耐受机制可能会导致对有害自身免疫性疾病患者的治疗。
我的实验设计涉及识别和表征适当的细胞发育和分化所必需的新分子。我使用基因组学(基因表达系列分析),
鉴定在不同T细胞群中差异表达的特定基因产物。然后,我用一种新的RNAi方法来表征这些分子,以产生基因特异性缺陷小鼠。简言之,将含有基因特异性shRNA的慢病毒引入纯化的造血干细胞(HSC)中。然后用HSC重建RAG 2-/-受体小鼠以产生基因特异性敲低小鼠。
通过这些结合基因组和RNAi的方法,我鉴定并表征了MINK
(畸形NIK相关激酶),这对胸腺中的阴性选择很重要。此外,我的目标是扩展这些方法的使用,以表征SAGE确定的其他分子。
这项研究将有助于识别对免疫反应重要的新分子,
自我宽容此外,对其生物学功能的快速表征将有助于理解和找到治疗自身免疫性疾病的适当靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nami McCarty其他文献
Nami McCarty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nami McCarty', 18)}}的其他基金
Delineating roles for a novel tri-protein complex (TRIM44) in the multiple myeloma stem cell niche
描述新型三蛋白复合物 (TRIM44) 在多发性骨髓瘤干细胞生态位中的作用
- 批准号:
9306792 - 财政年份:2016
- 资助金额:
$ 16.2万 - 项目类别:
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
靶向人类 MCL 中的干细胞依赖性耐药性
- 批准号:
9263689 - 财政年份:2014
- 资助金额:
$ 16.2万 - 项目类别:
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
靶向人类 MCL 中的干细胞依赖性耐药性
- 批准号:
8884564 - 财政年份:2014
- 资助金额:
$ 16.2万 - 项目类别:
Targeting Stem-Cell Dependent Drug Resistance in Human MCL
靶向人类 MCL 中的干细胞依赖性耐药性
- 批准号:
8760722 - 财政年份:2014
- 资助金额:
$ 16.2万 - 项目类别:
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells
分析多发性骨髓瘤干细胞样细胞中的蛋白质稳态途径
- 批准号:
10308685 - 财政年份:2014
- 资助金额:
$ 16.2万 - 项目类别:
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells
分析多发性骨髓瘤干细胞样细胞中的蛋白质稳态途径
- 批准号:
10520036 - 财政年份:2014
- 资助金额:
$ 16.2万 - 项目类别:
Characterizing Clonogenic Populations in Mantle Cell Lymphoma
套细胞淋巴瘤克隆形成群体的特征
- 批准号:
7992452 - 财政年份:2009
- 资助金额:
$ 16.2万 - 项目类别:
Characterizing Clonogenic Populations in Mantle Cell Lymphoma
套细胞淋巴瘤克隆形成群体的特征
- 批准号:
7788035 - 财政年份:2009
- 资助金额:
$ 16.2万 - 项目类别:
Identification and characterization of molecules important in the immune system
免疫系统中重要分子的鉴定和表征
- 批准号:
7284140 - 财政年份:2006
- 资助金额:
$ 16.2万 - 项目类别:
相似海外基金
Targeting LKB1-null lung adenocarcinoma with innate immune system
利用先天免疫系统靶向 LKB1 缺失的肺腺癌
- 批准号:
10752833 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
Program the Immune System against RAS-driven Cancer
对免疫系统进行编程以对抗 RAS 驱动的癌症
- 批准号:
10612257 - 财政年份:2023
- 资助金额:
$ 16.2万 - 项目类别:
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
肺内皮细胞作为血管损伤期间先天免疫系统的指导性生态位
- 批准号:
10494611 - 财政年份:2022
- 资助金额:
$ 16.2万 - 项目类别:
Reverse transcriptase-mediated expansion of the host innate immune system
逆转录酶介导的宿主先天免疫系统扩张
- 批准号:
10574416 - 财政年份:2022
- 资助金额:
$ 16.2万 - 项目类别:
Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells
肺上皮谱系特异性因子控制肿瘤细胞免疫系统逃避基因
- 批准号:
10201859 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Peripheral Adaptive Immune System Changes Associated with Alzhiemer's Disease
与阿尔茨海默病相关的外周适应性免疫系统变化
- 批准号:
10194864 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study
帕金森病和阿尔茨海默病的免疫系统衰老:基于人群的研究中的表观遗传学、生物衰老和增强的免疫状态
- 批准号:
10191858 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study
帕金森病和阿尔茨海默病的免疫系统衰老:基于人群的研究中的表观遗传学、生物衰老和增强的免疫状态
- 批准号:
10554384 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Lung epithelial lineage-specific factors in the control of immune system evasion genes in tumor cells
肺上皮谱系特异性因子控制肿瘤细胞免疫系统逃避基因
- 批准号:
10359835 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别:
Immune System Aging in Parkinson’s and Alzheimer’s disease: Epigenetics, biologic aging, and heightened immune states in a population-based study
帕金森病和阿尔茨海默病的免疫系统衰老:基于人群的研究中的表观遗传学、生物衰老和增强的免疫状态
- 批准号:
10396067 - 财政年份:2021
- 资助金额:
$ 16.2万 - 项目类别: